AUFORIA is a company founded in 2021 by a group of experts with many years of experience in the pharmaceutical industry, as well as pioneers in building the medical cannabis market in Poland.

We are based solely on Polish capital, focusing on quality, innovation, and safety, delivering top-quality products to patients in compliance with international standards.

Quality is the cornerstone of our business. Quality is the cornerstone of our business. AUFORIA pharmaceutical raw materials are produced according to the highest standards, meeting the requirements of EU-GMP (Good Manufacturing Practices) and GACP (Good Agricultural and Collection Practices).

Every stage of production – from cultivation to distribution – is carefully monitored. We conduct detailed laboratory tests, including analyses of active ingredients (THC and CBD), to ensure that our patients can fully trust the quality and effectiveness of AUFORIA products.

Our goal is not only to provide effective therapeutic solutions but also to educate and support patients and healthcare staff.

We understand that medical cannabis is still a new area in the Polish healthcare system, and that’s why we focus on providing reliable knowledge based on research and scientific studies. We aim to create a strong cannabis product brand that meets the real needs of patients.